{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:15:43Z","timestamp":1792649743250,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["ALTF 765-2019"],"award-info":[{"award-number":["ALTF 765-2019"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.trecan.2020.07.007","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T07:49:52Z","timestamp":1598255392000},"page":"1031-1043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Human-Derived Model Systems in Gynecological Cancer Research"],"prefix":"10.1016","volume":"6","author":[{"given":"Kadi","family":"L\u00f5hmussaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Boretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Clevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2020.07.007_bb0005","series-title":"Blaustein\u2019s Pathology of the Female Genital Tract","year":"2011"},{"key":"10.1016\/j.trecan.2020.07.007_bb0010","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.4161\/cc.25917","article-title":"Long-term label retaining cells localize to distinct regions within the female reproductive epithelium","volume":"12","author":"Patterson","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trecan.2020.07.007_bb0015","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/0192623317710012","article-title":"Normal developmental and estrous cycle-dependent histological features of the female reproductive organs in microminipigs","volume":"45","author":"Kangawa","year":"2017","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14584","article-title":"A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle","volume":"8","author":"Xiao","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2020.07.007_bb0025","first-page":"580","article-title":"Gynecologic malignancies in older women","volume":"15","author":"Mirhashemi","year":"2001","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.trecan.2020.07.007_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.steroids.2014.12.013","article-title":"Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers","volume":"99","author":"Brown","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.trecan.2020.07.007_bb0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI27987","article-title":"Estrogen receptors and human disease","volume":"116","author":"Deroo","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2020.07.007_bb0040","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrd2110","article-title":"The mighty mouse: genetically engineered mouse models in cancer drug development","volume":"5","author":"Sharpless","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.trecan.2020.07.007_bb0045","first-page":"845","article-title":"Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers. Clin","volume":"9","author":"Verschraegen","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2020.07.007_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2020.07.007_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103988","article-title":"Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes","volume":"9","author":"Beaufort","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.trecan.2020.07.007_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/856f0890-9d85-4719-8e54-c27530ac94f4","article-title":"Type-specific cell line models for type-specific ovarian cancer research","volume":"8","author":"Anglesio","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trecan.2020.07.007_bb0065","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.celrep.2018.10.096","article-title":"Integrated genomic, epigenomic, and expression analyses of ovarian cancer cell lines","volume":"25","author":"Papp","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2020.07.007_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8419","article-title":"Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours","volume":"6","author":"Ince","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2020.07.007_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14551-2","article-title":"A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity","volume":"11","author":"Nelson","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2020.07.007_bb0080","series-title":"Cancer Cell Culture","first-page":"133","article-title":"Isolation and culture of ovarian cancer cell lines","author":"Langdon","year":"2004"},{"key":"10.1016\/j.trecan.2020.07.007_bb0085","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1002\/jcp.26060","article-title":"MicroRNA-mediated drug resistance in ovarian cancer","volume":"234","author":"Mihanfar","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0090","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1038\/onc.2012.622","article-title":"EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF","volume":"32","author":"Gordon","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2020.07.007_bb0095","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1158\/0008-5472.CAN-10-0713","article-title":"High levels of Nrf2 determine chemoresistance in type II endometrial cancer","volume":"70","author":"Jiang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2020.07.007_bb0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/2159-8290.CD-11-0039","article-title":"High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability","volume":"1","author":"Cheung","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2020.07.007_bb0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/153303461000900207","article-title":"Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma","volume":"9","author":"Wang","year":"2010","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.trecan.2020.07.007_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3639-0","article-title":"Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors","volume":"17","author":"Philip","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.trecan.2020.07.007_bb0115","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/0008-5472.CAN-19-1382","article-title":"ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells","volume":"80","author":"Rodriguez","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2020.07.007_bb0120","doi-asserted-by":"crossref","first-page":"26662","DOI":"10.1074\/jbc.273.41.26662","article-title":"Characterization of distinct human endometrial carcinoma cell lines deficient in mismatch repair that originated from a single tumor","volume":"273","author":"Glaab","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.trecan.2020.07.007_bb0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrclinonc.2010.216","article-title":"Emerging therapeutic targets in endometrial cancer","volume":"8","author":"Dedes","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0130","doi-asserted-by":"crossref","first-page":"40402","DOI":"10.18632\/oncotarget.16316","article-title":"Oncogenic histone methyltransferase EZH2: a novel prognostic marker with therapeutic potential in endometrial cancer","volume":"8","author":"Oki","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trecan.2020.07.007_bb0135","doi-asserted-by":"crossref","first-page":"28042","DOI":"10.18632\/oncotarget.15886","article-title":"miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells","volume":"8","author":"Zhuo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trecan.2020.07.007_bb0140","first-page":"264","article-title":"Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium","volume":"12","author":"Gey","year":"1952","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2020.07.007_bb0145","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1073\/pnas.0408105102","article-title":"Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI)","volume":"102","author":"Sandberg","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2020.07.007_bb0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2164-8-117","article-title":"Quantitative gene expression assessment identifies appropriate cell line models for individual cervical cancer pathways","volume":"8","author":"Carlson","year":"2007","journal-title":"BMC Genomics"},{"key":"10.1016\/j.trecan.2020.07.007_bb0155","first-page":"569","article-title":"Human papilloma viruses and cancer. Bibl","volume":"43","author":"zur Hausen","year":"1975","journal-title":"Bibl. Haematol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0160","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1101\/gad.9.19.2335","article-title":"Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes","volume":"9","author":"Cheng","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.trecan.2020.07.007_bb0165","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.trecan.2020.07.007_bb0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2003.12.033","article-title":"Characterization of 10 vulvar carcinoma cell lines by karyotyping, comparative genomic hybridization and flow cytometry","volume":"93","author":"Raitanen","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111684","article-title":"Establishment of a novel cancer cell line derived from vulvar carcinoma associated with lichen sclerosus exhibiting a fibroblast-dependent tumorigenic potential","volume":"386","author":"Dongre","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.trecan.2020.07.007_bb0180","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/bjc.1995.289","article-title":"Human papillomavirus in vulvar and vaginal carcinoma cell lines","volume":"72","author":"Hietanen","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2020.07.007_bb0185","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/gcc.2870030604","article-title":"Consistent chromosome abnormalities in squamous cell carcinoma of the vulva","volume":"3","author":"Worsham","year":"1991","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.trecan.2020.07.007_bb0190","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1158\/0008-5472.CAN-09-3788","article-title":"Molecular target class is predictive of in vitro response profile","volume":"70","author":"Greshock","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2020.07.007_bb0195","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2020.07.007_bb0200","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2020.07.007_bb0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2020.07.007_bb0210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ygyno.2015.07.104","article-title":"Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies","volume":"139","author":"Depreeuw","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0215","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1158\/0008-5472.CAN-13-1069","article-title":"Patient-derived tumor xenografts: transforming clinical samples into mouse models","volume":"73","author":"Siolas","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2020.07.007_bb0220","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1158\/0008-5472.CAN-08-4808","article-title":"Evidence for cancer stem cells in human endometrial carcinoma","volume":"69","author":"Hubbard","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2020.07.007_bb0225","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrc3944","article-title":"Examining the utility of patient-derived xenograft mouse models","volume":"15","author":"Aparicio","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2020.07.007_bb0230","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/1078-0432.CCR-16-1237","article-title":"Establishment of patient-derived tumor xenograft models of epithelial ovarian cancer for preclinical evaluation of novel therapeutics","volume":"23","author":"Liu","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2020.07.007_bb0235","article-title":"Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts","volume":"9","author":"Liu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2020.07.007_bb0240","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41597-019-0225-0","article-title":"A multi-modal data resource for investigating topographic heterogeneity in patient-derived xenograft tumors","volume":"6","author":"Rajaram","year":"2019","journal-title":"Sci. Data"},{"key":"10.1016\/j.trecan.2020.07.007_bb0245","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nature13952","article-title":"Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution","volume":"518","author":"Eirew","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2020.07.007_bb0250","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ng.3967","article-title":"Patient-derived xenografts undergo mouse-specific tumor evolution","volume":"49","author":"Ben-David","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.trecan.2020.07.007_bb0255","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4143\/crt.2016.322","article-title":"Patient-derived xenograft models of epithelial ovarian cancer for preclinical studies","volume":"49","author":"Heo","year":"2017","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.trecan.2020.07.007_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024420","article-title":"Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis","volume":"6","author":"Bankert","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.trecan.2020.07.007_bb0265","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1158\/0008-5472.CAN-14-0274","article-title":"Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations","volume":"74","author":"Ricci","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2020.07.007_bb0270","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.molonc.2014.01.008","article-title":"Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts","volume":"8","author":"Topp","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0275","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89760","article-title":"A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers","volume":"2","author":"George","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.trecan.2020.07.007_bb0280","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/1878-0261.12414","article-title":"Targeting HER2 in patient-derived xenograft ovarian cancer models sensitizes tumors to chemotherapy","volume":"13","author":"Harris","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0285","doi-asserted-by":"crossref","first-page":"24707","DOI":"10.18632\/oncotarget.25185","article-title":"Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts","volume":"9","author":"Guffanti","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.trecan.2020.07.007_bb0290","doi-asserted-by":"crossref","first-page":"23720","DOI":"10.18632\/oncotarget.4690","article-title":"Critical role of Wnt\/\u03b2-catenin signaling in driving epithelial ovarian cancer platinum resistance","volume":"6","author":"Nagaraj","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.trecan.2020.07.007_bb0295","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ygyno.2014.02.022","article-title":"Assessing the efficacy of targeting the phosphatidylinositol 3-kinase\/AKT\/mTOR signaling pathway in endometrial cancer","volume":"133","author":"Bradford","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0300","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1080\/15384047.2017.1281496","article-title":"The allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer","volume":"18","author":"Winder","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.trecan.2020.07.007_bb0305","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1200\/EDBK_280503","article-title":"A review of immune checkpoint blockade therapy in endometrial cancer","author":"Green","year":"2020","journal-title":"Am. Soc. Clin. Oncol. Educ. B."},{"key":"10.1016\/j.trecan.2020.07.007_bb0310","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2008.03.011","article-title":"Xenografts of primary human gynecological tumors grown under the renal capsule of NOD\/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy","volume":"110","author":"Press","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0315","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/978-1-4939-2013-6_28","article-title":"Establishment of orthotopic primary cervix cancer xenografts","volume":"1249","author":"Chaudary","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0320","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2010.03.019","article-title":"Creation and characterization of a xenograft model for human cervical cancer","volume":"118","author":"Hoffmann","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0325","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.14694\/EdBook_AM.2014.34.e258","article-title":"Patient-derived xenograft models in gynecologic malignancies","author":"Scott","year":"2014","journal-title":"Am. Soc. Clin. Oncol. Educ. book. Am. Soc. Clin. Oncol. Annu. Meet."},{"key":"10.1016\/j.trecan.2020.07.007_bb0330","doi-asserted-by":"crossref","first-page":"36219","DOI":"10.18632\/oncotarget.5283","article-title":"HER2 as a novel therapeutic target for cervical cancer","volume":"6","author":"Oh","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.trecan.2020.07.007_bb0335","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1126\/science.aao3130","article-title":"Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer","volume":"358","author":"Drost","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.trecan.2020.07.007_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9989","article-title":"The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids","volume":"6","author":"Kessler","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2020.07.007_bb0345","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2020.07.007_bb0350","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1158\/2159-8290.CD-18-0474","article-title":"Prediction of DNA repair inhibitor response in short-term patient-derived ovarian cancer organoids","volume":"8","author":"Hill","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2020.07.007_bb0355","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2019.05.005","article-title":"Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors","volume":"154","author":"Maru","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0360","doi-asserted-by":"crossref","first-page":"955","DOI":"10.15252\/msb.20177697","article-title":"Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations","volume":"13","author":"Jabs","year":"2017","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0365","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.stemcr.2020.03.004","article-title":"Developing organoids from ovarian cancer as experimental and preclinical models","volume":"14","author":"Maenhoudt","year":"2020","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.trecan.2020.07.007_bb0370","article-title":"Single cell derived organoids capture the self-renewing subpopulations of metastatic ovarian cancer","author":"Velletri","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.trecan.2020.07.007_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107762","article-title":"Patient-derived ovarian cancer organoids mimic clinical response and exhibit heterogeneous inter- and intrapatient drug responses","volume":"31","author":"de Witte","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2020.07.007_bb0380","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/BF02620878","article-title":"Gland formation from human endometrial epithelial cells in vitro","volume":"24","author":"Rinehart","year":"1988","journal-title":"In Vitro Cell. Dev. Biol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0385","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1242\/dev.148478","article-title":"Development of organoids from mouse and human endometrium showing endometrial epithelium physiology and long-term expandability","volume":"144","author":"Boretto","year":"2017","journal-title":"Development"},{"key":"10.1016\/j.trecan.2020.07.007_bb0390","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ncb3516","article-title":"Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium","volume":"19","author":"Turco","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0395","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41556-019-0360-z","article-title":"Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening","volume":"21","author":"Boretto","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0400","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","article-title":"Personalized in vitro and in vivo cancer models to guide precision medicine","volume":"7","author":"Pauli","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2020.07.007_bb0405","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cell.2018.07.027","article-title":"Divergent routes toward Wnt and R-spondin niche independency during human gastric carcinogenesis","volume":"174","author":"Nanki","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2020.07.007_bb0410","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.stem.2017.12.009","article-title":"Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression","volume":"22","author":"Seino","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trecan.2020.07.007_bb0415","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature14415","article-title":"Sequential cancer mutations in cultured human intestinal stem cells","volume":"521","author":"Drost","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2020.07.007_bb0420","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/IGC.0000000000001061","article-title":"The use of endometrial cancer patient-derived organoid culture for drug sensitivity testing is feasible","volume":"27","author":"Girda","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.trecan.2020.07.007_bb0425","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1111\/cas.14119","article-title":"Establishment and characterization of patient-derived organoids from a young patient with cervical clear cell carcinoma","volume":"110","author":"Maru","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.trecan.2020.07.007_bb0430","article-title":"Transition of Wnt signaling microenvironment delineates the squamo-columnar junction and emergence of squamous metaplasia of the cervix","author":"Chumduri","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.trecan.2020.07.007_bb0435","doi-asserted-by":"crossref","first-page":"26580","DOI":"10.1073\/pnas.1911273116","article-title":"Pancreatic cancer organoids recapitulate disease and allow personalized drug screening","volume":"116","author":"Driehuis","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2020.07.007_bb0440","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trecan.2020.07.007_bb0445","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","article-title":"A rectal cancer organoid platform to study individual responses to chemoradiation","volume":"25","author":"Ganesh","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2020.07.007_bb0450","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/2159-8290.CD-18-1522","article-title":"Oral mucosal organoids as a potential platform for personalized cancer therapy","volume":"9","author":"Driehuis","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2020.07.007_bb0455","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.trecan.2020.07.007_bb0460","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Getz","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2020.07.007_bb0465","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2020.07.007_bb0470","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2020.07.007_bb0475","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1073\/pnas.0806514106","article-title":"Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation","volume":"106","author":"Salvesen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2020.07.007_bb0480","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","article-title":"Integrated molecular characterization of uterine carcinosarcoma","volume":"31","author":"Cherniack","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2020.07.007_bb0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01217-9","article-title":"Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma","volume":"8","author":"Ducie","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2020.07.007_bb0490","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cell.2020.01.026","article-title":"Proteogenomic characterization of endometrial carcinoma","volume":"180","author":"Dou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2020.07.007_bb0495","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","article-title":"Comprehensive characterization of cancer driver genes and mutations","volume":"173","author":"Bailey","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2020.07.007_bb0500","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41598-017-14676-3","article-title":"Comprehensive single-cell transcriptome analysis reveals heterogeneity in endometrioid adenocarcinoma tissues","volume":"7","author":"Hashimoto","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2020.07.007_bb0505","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-018-0024-3","article-title":"Intra-tumour diversification in colorectal cancer at the single-cell level","volume":"556","author":"Roerink","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2020.07.007_bb0510","doi-asserted-by":"crossref","first-page":"11426","DOI":"10.1128\/JVI.01721-13","article-title":"Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16","volume":"87","author":"Richards","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0515","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1073\/pnas.0508815103","article-title":"Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection","volume":"103","author":"Richards","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2020.07.007_bb0520","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1128\/jvi.63.10.4317-4324.1989","article-title":"The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes","volume":"63","author":"Bernard","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0525","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1128\/JVI.75.16.7583-7591.2001","article-title":"Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7","volume":"75","author":"Gonzalez","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.trecan.2020.07.007_bb0530","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","article-title":"The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53","volume":"63","author":"Scheffner","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2020.07.007_bb0535","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-05519-2","article-title":"Directed differentiation of human induced pluripotent stem cells into fallopian tube epithelium","volume":"7","author":"Yucer","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803320302156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803320302156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:51:53Z","timestamp":1762505513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803320302156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":107,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2405803320302156"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2020.07.007","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human-Derived Model Systems in Gynecological Cancer Research","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2020.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}